Replies to post #174185 on Biotech Values

[zipjet]

$RTRX Roth Capital raised their price target to $51 per share.

[kris_kade]

If he sells now than it becomes an issue.

[biomaven0]

>>Why isn't this insider buy considered acting on inside information?

In virtually all acquisitions, the acquiring company stock goes down on the announcement. Sure there have been some exceptions (JAZZ/GENT a recent notable example), but those are pretty unusual.

Peter